Anatrace

Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.

Pharmaron is a contract research organization (CRO).

Services:
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services

www.pharmaron.com

CRO - Contract Research Organization
Library Synthesis
CADD
Bioorganic Chemistry
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
ChemInformatics
in vitro Biology
in vitro Screening
Structural Biology
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
Biomarkers
in vitro ADME
in vivo PK
PKPD
QA
Regulatory Affairs
Discovery Biologics
Process Chemistry
API Manufacturing
Material Science
Formulation Development
Drug Product Manufacturing
Toxicology
Safety Pharmacology
Genetic Toxicology
DART
Pathology
Immunotoxicity
Bioanalytical
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
QWBA
mARG
Clinical AME
Mass Balance
Metabolite Profiling
Microdosing Phase 0
Absolute Bioavailability
DDI
First-in-Human (FIH)
Thorough QT(TQT)
Ethnobridging

A1 BioChem Labs (ABCL) is a Contract Research Organization located in Wilmington, North Carolina. Our primary focus is offering top notch custom synthesis chemistry services to Pharmaceutical Companies, Biotech’s, Universities, and Research Institutes. With an emphasis on speed, quality, communication, and pricing we provide customers with a reliable source for any chemistry needs.

In addition to custom synthesis work we also have an expanding catalog of compounds consisting of fine chemicals, scaffolds, and building blocks. Our collection consists of structurally diverse compounds that are useful to drug discovery and development efforts. With a focus on customer service we will provide you with a seamless experience.

Aurora Fine Chemicals is a privately held company that was founded in 1990. As a chemicals R&D supplier we offer chemicals for R&D, drug discovery service, compound libraries and custom synthesis. We have one of the largest collections of 18.1 mln. chemicals available in stock and our docking software delivers hits/leads of very high quality in short time.

Our staff consists of highly qualified individuals with Bsc, Msc and Ph.D. degrees in chemistry, as well as excellent laboratory technicians. In our Molecular Modeling Group are professionals specializing in computational drug design. They possess many years experience of working in the chemistry of heterocycles, carbohydrates, nucleosides and elemental organic compounds. Aurora has significant expertise in synthesis of all types R&D chemicals for drug discovery like small molecules, natural products and peptides. Parallel synthesis with well-designed, targeted and fragment-based libraries is the favored approach to lead optimization. Rational design is the strategy for projects driven by structural biology, such as enzyme inhibitors or protein interactions.

We own a large library of 18.1 million stocked compounds for R&D. Our substances are used in many research labs all over the world. We offer structures for biochemical and chemical research. Our products are applied in pharmaceutical development, diagnosis, and in chemical production.

Several laboratories for synthesis with modern equipment such as reactors, autoclaves, thermostats and hydrogenation equipment are available.

Intermediates and final products are analyzed by GC, HPLC, IR, NMR, MS, elemental analysis, atom-absorption analysis and crystallographical methods.

The main advantage of Aurora's own software is the quality of the underlying physical models. Aurora's software derives molecular properties from first principles based on direct models using advanced quantum mechanical analysis of molecular interactions and thermodynamics.

Biotranex is a science-driven Contract Research Organization (CRO) that provides clients with a full range of ADMET and pharmacokinetic laboratory and consulting services to facilitate drug discovery and development. Services that Biotranex offers include metabolite profiling and structural elucidation; drug-drug interaction studies; CYP induction and inhibition; CYP and UGT phenotyping; transporter inhibition and phenotyping; metabolite biosynthesis; subcellular, hepatocyte, and animal studies; biotransformation; and pharmacokinetic studies. The Biotranex team of scientists has extensive collective experience in the pharmaceutical industry and proven drug discovery and development successes, as well as extensive experience with IND and NDA regulatory filings.

Wildcat Discovery Technologies accelerates the discovery of new materials for energy applications, with a focus on the development of advanced materials for rechargeable and primary batteries. Wildcat’s business also includes collaborative development projects for materials for other applications, including gas storage, carbon capture, thermoelectrics, and structural materials.

Wildcat synthesizes and evaluates thousands of materials every week. To do this, we use proprietary unique-in-the-world high throughput synthesis and testing platforms to rapidly explore thousands of new materials with the goal of improving performance and reducing costs.

Our massively parallel combinatorial chemistry approach reduces R&D costs and speeds time to market. The reduction in experimental cost also enables exploration of high risk targets that are often never explored. For example, one battery project involved the exploration of over 1000 unique electrolyte formulations in less than three months.

Wildcat employs an experienced team of scientists and engineers, with backgrounds in batteries, materials development, and high throughput automation. We also have a world class scientific advisory board.

Wildcat is pursuing partnership and collaboration opportunities with corporate leaders throughout the battery supply chain, including global material suppliers, cell makers, and OEM’s throughout the automotive, electronics, medical, military, and consumer products industries.